Pfizer vaccine 95% effective in final analysis, plans to seek emergency authorization ‘within days’
By SONY SALZMAN, ABC News(NEW YORK) -- Pfizer and partner BioNTech announced their coronavirus vaccine is more than 95% effective in the final analysis of its massive Phase 3 trial on Wednesday, and has reached a key safety milestone that... Read More.